Viewing Study NCT02915302


Ignite Creation Date: 2025-12-25 @ 3:47 AM
Ignite Modification Date: 2026-03-03 @ 11:55 PM
Study NCT ID: NCT02915302
Status: COMPLETED
Last Update Posted: 2022-03-29
First Post: 2016-09-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Immunogenicity of FluzoneĀ® Quadrivalent Vaccine Administered to Healthy Children
Sponsor: Sanofi Pasteur, a Sanofi Company
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-09-23
Start Date Type: None
Primary Completion Date: 2017-03-06
Primary Completion Date Type: ACTUAL
Completion Date: 2017-03-06
Completion Date Type: ACTUAL
First Submit Date: 2016-09-23
First Submit QC Date: None
Study First Post Date: 2016-09-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2018-03-06
Results First Submit QC Date: None
Results First Post Date: 2018-04-03
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-03-15
Last Update Post Date: 2022-03-29
Last Update Post Date Type: ACTUAL